Crossmark

ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer may Reduce Microscopic Venous Invasion, Which is an Independent Prognostic Factor Associated with Liver Recurrence

Crossref DOI link: https://doi.org/10.1245/s10434-022-11662-6

Published Online: 2022-04-05

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kubo, Hidemasa

Ohgi, Katsuhisa

Sugiura, Teiichi

Ashida, Ryo

Yamada, Mihoko

Otsuka, Shimpei

Yamazaki, Kentaro

Todaka, Akiko

Sasaki, Keiko

Uesaka, Katsuhiko
License Information

Text and Data Mining valid from 2022-04-05

Version of Record valid from 2022-04-05
More Information

Article History

Received: 10 March 2022

Accepted: 11 March 2022

First Online: 5 April 2022

Disclosure

: The authors declare no conflicts of interest.

Document is current

Any future updates will be listed below